PF-Atlas › Clinical Trials › NCT03502902

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

HEC 68498 · Phase 1

Registry ID

NCT03502902

Phase

Phase 1

Status

Completed

Drug / intervention

HEC 68498

Sponsor

Sunshine Lake Pharma Co., Ltd.

Start

2018-04-26

Enrollment

Locations

About this trial

A Phase I, Double-blind, Placebo-controlled, Single Oral Dose, Safety, Tolerability, and Pharmacokinetic Study, Incorporating an Evaluation of the Effect of Food on the Pharmacokinetics of HEC68498 in Healthy Male and Female Subjects

View NCT03502902 on ClinicalTrials.gov →

Explore related

All HEC 68498 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT03502902 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.